|
FR580494A
(fr)
|
1923-07-10 |
1924-11-07 |
Const Metalliques Schiltigheim |
Procédé d'établissement des buses d'aération ou autres tuyaux
|
|
US2837464A
(en)
|
1955-01-11 |
1958-06-03 |
Schering Corp |
Process for production of dienes by corynebacteria
|
|
DE1059906B
(de)
|
1954-10-05 |
1959-06-25 |
Scherico Ltd |
Verfahren zur Herstellung von 1, 4-Pregnadienen
|
|
US3067197A
(en)
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
|
GB1047518A
(en)
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
GB1158492A
(en)
|
1966-02-09 |
1969-07-16 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
US3639434A
(en)
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
IT1061787B
(it)
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1227992A
(https=)
|
1968-01-23 |
1971-04-15 |
Koninklijke Gist Spiritus |
|
|
IT1034011B
(it)
|
1969-06-26 |
1979-09-10 |
Vister Vismara Terapeutici S P |
Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
|
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
|
US3828080A
(en)
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
|
US3989686A
(en)
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1438940A
(en)
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
|
GB1440063A
(en)
|
1972-08-11 |
1976-06-23 |
Glaxo Lab Ltd |
17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
|
|
DE2336693A1
(de)
|
1973-07-19 |
1975-02-06 |
Nassheuer Ind Ofenbau Jean |
Strahlheizrohr
|
|
US4093721A
(en)
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
|
YU54476A
(en)
|
1975-03-31 |
1982-05-31 |
Taisho Pharmaceutical Co Ltd |
Process for obtaining 17-ester 21-halo-pregnane
|
|
DE2538569A1
(de)
|
1975-08-29 |
1977-03-03 |
Siemens Ag |
Verfahren zur metallisierung von duroplasten
|
|
CH628355A5
(de)
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
US4221787A
(en)
|
1978-03-28 |
1980-09-09 |
Interx Research Corporation |
Esteramide prodrugs of anti-inflammatory corticosteroids
|
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4261984A
(en)
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
|
US4188385A
(en)
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4198403A
(en)
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
|
US4263289A
(en)
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
DE2817988A1
(de)
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
|
US4310466A
(en)
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4267173A
(en)
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
|
BE887518A
(fr)
|
1980-02-15 |
1981-08-13 |
Glaxo Group Ltd |
Cartothioates d'androstanes
|
|
GB2088877B
(en)
|
1980-02-15 |
1984-07-04 |
Glaxo Group Ltd |
Androstane 17 carbothioates
|
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
ZA814440B
(en)
|
1980-07-10 |
1982-10-27 |
Otsuka Pharma Co Ltd |
Soft steroids having anti-inflammatory activity
|
|
US4710495A
(en)
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US4607028A
(en)
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
|
EP0179583A1
(en)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
|
|
US4861765A
(en)
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
|
ZA872389B
(en)
|
1987-04-02 |
1987-11-25 |
Advanced Polymer Systems Inc |
Composition and method for delivering a steroid active ingredient
|
|
DE3786174T2
(de)
|
1987-10-13 |
1993-10-21 |
Nicholas S Bodor |
Weiche steroide mit anti-entzündungswirkung.
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
FR2644788B1
(fr)
|
1989-03-22 |
1995-02-03 |
Roussel Uclaf |
Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
|
US5202316A
(en)
|
1989-03-22 |
1993-04-13 |
Roussel Uclaf |
N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines
|
|
JPH07116215B2
(ja)
|
1989-04-19 |
1995-12-13 |
エスエス製薬株式会社 |
新規なステロイド化合物
|
|
WO1990015816A1
(en)
|
1989-06-16 |
1990-12-27 |
The Upjohn Company |
Suramin type compounds and angiostatic steroids to inhibit angiogenesis
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
DE4025342A1
(de)
|
1990-08-10 |
1992-02-13 |
Hoechst Ag |
In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
|
US5250293A
(en)
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
|
TW247878B
(https=)
|
1991-07-02 |
1995-05-21 |
Takeda Pharm Industry Co Ltd |
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
ES2122261T3
(es)
|
1993-03-17 |
1998-12-16 |
Minnesota Mining & Mfg |
Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
|
|
DE4328819A1
(de)
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
DE4333920A1
(de)
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
US5420120A
(en)
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
|
GB9419536D0
(en)
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
AR002009A1
(es)
|
1994-12-22 |
1998-01-07 |
Astra Ab |
Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
|
|
JPH08291073A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
医薬品組成物及びその製造方法
|
|
JPH08291072A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
吸入用粉末製剤用結晶とその製造方法
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
US5707984A
(en)
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
|
CN1133643C
(zh)
|
1995-12-29 |
2004-01-07 |
葛兰素集团有限公司 |
17-β-羧基,羰基硫代以及酰胺雄甾烷衍生物的内酯衍生物
|
|
US5985862A
(en)
|
1996-05-02 |
1999-11-16 |
G.D. Searle & Co. |
Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5981517A
(en)
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
AU3153797A
(en)
|
1996-06-04 |
1998-01-05 |
Procter & Gamble Company, The |
A nasal spray containing an intranasal steroid and an antihistamine
|
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
|
US5919776A
(en)
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
ES2239801T3
(es)
|
1997-04-02 |
2005-10-01 |
The Brigham And Women's Hospital, Inc. |
Uso de un agente para disminuir el riesgo de enfermedad cardiovascular.
|
|
AU8439998A
(en)
|
1997-06-30 |
1999-01-25 |
Glaxo Group Limited |
Compounds
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
|
US5972920A
(en)
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
AU3411000A
(en)
|
1999-03-24 |
2000-10-09 |
Glenayre Electronics, Inc |
Computation and quantization of voiced excitation pulse shapes in linear predictive coding of speech
|
|
MXPA01011018A
(es)
|
1999-04-30 |
2002-05-06 |
Pfizer Prod Inc |
Moduladores del receptor glucocorticoide.
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US20020081266A1
(en)
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
|
EP1212101A1
(en)
|
1999-08-31 |
2002-06-12 |
The Brigham And Women's Hospital, Inc. |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
US7413536B1
(en)
|
1999-09-14 |
2008-08-19 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
MXPA02007252A
(es)
|
2000-01-28 |
2003-01-29 |
Rohm & Haas |
Compuestos farmaceuticos con propiedades mejoradas.
|
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
|
GB0009591D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical combinations
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
|
JP2004504357A
(ja)
|
2000-07-26 |
2004-02-12 |
アルコン，インコーポレイテッド |
ポリマー性懸濁化剤を含有しない薬学的懸濁組成物
|
|
KR100331704B1
(ko)
|
2000-07-31 |
2002-04-09 |
윤길림 |
인터넷을 이용한 프로그램 임대시스템
|
|
US6858593B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777400B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
SI1775305T1
(sl)
|
2000-08-05 |
2015-01-30 |
Glaxo Group Limited |
S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
US6787532B2
(en)
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
AR032362A1
(es)
|
2000-08-14 |
2003-11-05 |
Glaxo Group Ltd |
Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
|
|
BR0114321A
(pt)
|
2000-09-29 |
2003-07-01 |
Glaxo Group Ltd |
Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto
|
|
CA2436540C
(en)
|
2000-10-31 |
2008-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
|
JP3691487B2
(ja)
|
2000-12-22 |
2005-09-07 |
久光メディカル株式会社 |
炎症性気道疾患の予防・治療剤
|
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
|
ES2296923T3
(es)
|
2001-03-22 |
2008-05-01 |
Glaxo Group Limited |
Derivados formanilidas como agonistas del adrenorreceptor beta2.
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20050070487A1
(en)
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
KR100831534B1
(ko)
|
2001-04-30 |
2008-05-22 |
글락소 그룹 리미티드 |
17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체
|
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
|
US20030018019A1
(en)
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
WO2003013427A2
(en)
|
2001-08-03 |
2003-02-20 |
Smithkline Beecham Corporation |
A method for preparing fluticasone derivatives
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2003040691A2
(en)
|
2001-11-05 |
2003-05-15 |
The Brigham And Women's Hospital, Inc. |
Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
|
|
WO2003042229A1
(en)
|
2001-11-12 |
2003-05-22 |
Glaxo Group Limited |
Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
|
|
GB0127160D0
(en)
|
2001-11-12 |
2002-01-02 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
|
JP3691459B2
(ja)
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
|
GB0217504D0
(en)
|
2002-07-29 |
2002-09-04 |
Novartis Ag |
Organic compounds
|
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|